Filing metadata

Accession number
0001104659-17-033537
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
May 17, 2017
Reporting period
Feb 16, 2017
Description
Insider transaction

Explore SEC Filings Hub